Cosmo Clinical Research Llp - Company Profile

It is a pharma limited liability partnership based in Ambattur, Tamil Nadu, India, established in 2022.
2022 Ambattur, Tamil Nadu, India Active
Last Updated:
Access Report
About Cosmo Clinical Research Llp

Cosmo Clinical Research Llp, a active limited liability partnership, was established on 20 May 2022 in Ambattur, Tamil Nadu, India. Engaging in pharma contract r&d within the pharma sector, it holds LLPIN: ABB-0800. Registered under ROC Roc Chennai. It has total obligation of contribution of ₹0.30 M.

Its leadership includes Olaganathan Arumugam Arjun (Designated Partner), Olaganathan Meenakshi (Designated Partner), Arumugam Olaganathan (Designated Partner). Its latest date of accounts and solvency statement 31 March 2024. It is based at No. 12 A/2, Spartan Nagar, Ambattur, Tamil Nadu, 600037.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    ABB-0800

  • Incorporation Date

    20 May 2022

  • Total Obligation of Contribution

    ₹0.30 M

  • ROC Code

    Roc Chennai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.30 M
  • Company Age 3 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
Company report

Cosmo Clinical Research Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cosmo Clinical Research Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Cosmo Clinical Research Llp?
Current Designated Partners
Name Designation Appointment Date Status
Olaganathan Arumugam Arjun Designated Partner 20 May 2022 Current
Olaganathan Meenakshi Designated Partner 20 May 2022 Current
Arumugam Olaganathan Designated Partner 20 May 2022 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cosmo Clinical Research Llp.

Enhance accessibility to Cosmo Clinical Research Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cosmo Clinical Research Llp revenue growth over time
Cosmo Clinical Research Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cosmo Clinical Research Llp?

Unlock access to Cosmo Clinical Research Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cosmo Clinical Research Llp?

Unlock and access historical data on people associated with Cosmo Clinical Research Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cosmo Clinical Research Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cosmo Clinical Research Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cosmo Clinical Research Llp
Recent Activity within the Organization
  • Annual General Meeting

    Cosmo Clinical Research Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    The activity Cosmo Clinical Research Llp has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was completed.

  • Director Appointment

    Progress on Olaganathan Arumugam Arjun was appointed as a Designated Partner was appointed as a Designated Partner on 20 May 2022 & has been associated with this company since 3 years 9 months . was documented.

  • Director Appointment

    Progress on Olaganathan Meenakshi was appointed as a Designated Partner was appointed as a Designated Partner on 20 May 2022 & has been associated with this company since 3 years 9 months . was documented.

  • Director Appointment

    Progress on Arumugam Olaganathan was appointed as a Designated Partner was appointed as a Designated Partner on 20 May 2022 & has been associated with this company since 3 years 9 months . was documented.

  • LLP Incorporation

    The activity Cosmo Clinical Research Llp was registered on 20 May 2022 with Roc Chennai & aged 3 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Cosmo Clinical Research Llp?

The LLPIN of Cosmo Clinical Research Llp is ABB-0800.

Where is Cosmo Clinical Research Llp headquartered?

Cosmo Clinical Research Llp is headquartered at No. 12 A/2, Spartan Nagar, Ambattur, Tamil Nadu, 600037.

When was Cosmo Clinical Research Llp incorporated?

Cosmo Clinical Research Llp was incorporated on 20 May 2022.

Who are the current directors of Cosmo Clinical Research Llp?

The current directors of Cosmo Clinical Research Llp are

What is the primary industry of Cosmo Clinical Research Llp?

The primary industry of Cosmo Clinical Research Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available